Course Code: REL-ACU-0-RACD
Hours: 1
Type: Online Course
Content Expiration Date: 12/31/2025
Learning Objectives:
Review the epidemiology and pathophysiology of RA.
Recall symptoms and diagnostic criteria for RA.
Identify appropriate treatments and other considerations for patients with RA.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Overview
Meet Sylvia
Background
Epidemiology
Pathophysiology
Key Takeaways
Section 3: Diagnosis
Symptoms and General Diagnostic Overview
ACR-EULAR Diagnostic Criteria
Labs
Imaging
Key Takeaways
Section 4: Treatment Considerations
Overview
NSAIDs
Steroids
Immunosuppressive Agents
csDMARDs
bDMARDS (Biologics)
tsDMARDS (Biologics)
IVIG or SCIG
Diet
Physical and Occupational Therapy
Section 5: Other Considerations
Macrophage Activation Syndrome (MAS)
Vaccines and Preventative Measures
Quality of Life and Coping
Section 6: Clinical Vignette
Section 7: Conclusion
Course Summary
Course Contributor
Resources
References
Subject Matter Expert: Shalla Newton, MSN, RN, NE-BC
Shalla is a subject matter expert (SME)/writer for Relias. She completed her BSN and two undergraduate degrees with top honors from the University of Wisconsin-Madison. Shalla earned her dual MSN degrees from Johns Hopkins University with top honors. She also maintains her post-baccalaureate nurse educator certificate (NE-BC). Shalla’s tenure spans over 20 years of cross-functional leadership and direct clinical roles in healthcare, biopharma/biotech, government affairs, managed care/market access, nonprofit patient advocacy, and research. Her subject matter expertise is in rare, orphan, and complex diseases. Her sub-expertise is in immune-mediated diseases (rheumatology and immunology), genetics, neurology, hematology/oncology, several pediatric diseases, population/public health, and larger systemic healthcare affairs. Shalla is a published author with leading rare disease experts and a global speaker. She also sits on scientific, advocacy, and legislative advisory boards. She has led national advocacy and disease awareness campaigns, including speaking before congress, leading to the first-in-class rare disease biologic approval and investigative treatment protocols.
Target Audience:
The target audience for this course is: Laboratory Personnel; Nursing Personnel; in the following settings: Hospitals: Acute.
Relias Learning will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Relias Learning has a grievance policy in place to facilitate reports of dissatisfaction. Relias Learning will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias Learning at support@reliaslearning.com.
All courses offered by Relias Learning, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Course Delivery Method and Format
Asynchronous Distance Learning with interactivity which includes quizzes with questions/answers, and posttests.